Chargement en cours...
The challenge of modulating β-cell autoimmunity in type 1 diabetes
With the conceptual advance some four decades ago that type 1 diabetes (T1D) represents an autoimmune disease, hope emerged that immune-based therapies would quickly evolve as a means to prevent and reverse the disorder. However, despite dozens of clinical trials seeking to achieve that purpose, the...
Enregistré dans:
| Publié dans: | Lancet Diabetes Endocrinol |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7322790/ https://ncbi.nlm.nih.gov/pubmed/30528099 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2213-8587(18)30112-8 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|